4519 JP3519400000

Report

Delayed Japan Exchange - 02:00:00 2023-03-31 am EDT
3270.00	JPY		+0.83%

06:19a	Jefferies Adjusts Chugai Pharmaceutical's Price Target to 3,900 Yen From 4,200 Yen, Keeps at Buy	MT
05:59a	Chugai Pharmaceutical to Award Restricted Stock Compensation	MT
04:14a	Chugai Pharmaceutical : Voting Results (Extraordinary Report) of the 112th Annual General Meeting of Shareholders	PU

Sector news Other Pharmaceuticals

04:26a	Hutchmed Completes Rolling Submission of New Drug Application for Colorectal Cancer Dru..	MT
03/30	PDS Biotechnology Plans Late-Stage Combo Trial in Head, Neck Cancer in Q4	MT
03/30	Alembic Pharmaceuticals Gets Final US FDA Nod for Brimonidine Tartrate Ophthalmic Solu..	MT
03/29	Merck & Company Therapy Gets FDA Approval to Treat Solid Tumors	MT
03/29	Merck Announces U.S. Food and Drug Administration Grants Full Approval to KEYTRUDA for ..	CI
03/29	Sector Update: Health Care Stocks Steady Late Wednesday	MT
03/29	Novo Nordisk says stopping obesity drug may cause full weight regain in 5 years	RE
03/29	Sector Update: Health Care Stocks Mixed on Wednesday Afternoon	MT
03/29	UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating	MT
03/29	WHO to consider adding obesity drugs to 'essential' medicines list	RE
03/29	Johnson & Johnson Unit to Discontinue Respiratory Syncytial Virus Vaccine Program in Ad..	MT
03/29	STAAR Surgical Appoints Warren Foust as Chief Operating Officer	MT
03/29	Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO	AN
03/28	AbbVie Inc. Enter into an Amended and Restated Revolving Credit Agreement with JPMorgan..	CI
03/28	Viking joins obesity drug race after promising early trial data	RE
03/27	Merck & Co., Inc. Announces Results from the Phase 3 NRG-Gy018 Trial Investigating Keyt..	CI
03/24	NOVO NORDISK : JP Morgan maintains a Buy rating	MD
03/24	Sector Update: Health Care Stocks Higher in Late Afternoon Trading	MT
03/24	Novo Nordisk Reports Higher Semaglutide Doses Reach Targets in Late-Stage Trial	MT
03/24	Higher Doses of Novo Nordisk's Semaglutide Shows Blood Sugar Level Reduction in Late-st..	MT
03/24	Novo Nordisk Announces Headline Results from the Pioneer Plus 3 Trial	CI
03/24	Gerresheimer in demand - JPMorgan underpins optimism	DP
03/23	Janssen Pharmaceutical Says Health Canada Authorizes Expanded Use of Imbruvica in Combi..	MT
03/23	Novo Nordisk A/S Appoints Members of Committees	CI
03/23	Novo Nordisk A/S Announces Final Dividend for 2022	CI
03/23	AbbVie Says Risankizumab Phase 3 Trial, Upadacitinib Phase 2 Trial Achieve Respective P..	MT
03/23	AbbVie's Skyrizi Hits Goals in Ulcerative Colitis Study	DJ
03/23	Transcript : Novo Nordisk A/S - Shareholder/Analyst Call	CI
03/23	AbbVie Advances Upadacitinib (RINVOQ®) to Phase 3 Clinical Trials in Systemic Lupus Ery..	CI
03/23	Risankizumab (Skyrizi®) Achieves Primary and All Secondary Endpoints in Phase 3 Inducti..	CI
03/23	NOVO NORDISK : JP Morgan reiterates its Buy rating	MD
03/22	AbbVie Says US FDA Requests More Information on ABBV-951 New Drug Application	MT
03/22	FDA Rejects AbbVie Parkinson's Treatment; Seeks More Data	DJ
03/22	AbbVie Provides Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New D..	CI
03/22	NOVO NORDISK : Deutsche Bank reaffirms its Buy rating	MD
03/22	Dewpoint Therapeutics Partners with Novo Nordisk to Explore the Field of Biomolecular C..	CI
03/22	Roche, Eli Lilly Join Forces to Develop Blood Test for Early Detection of Alzheimer's D..	MT
03/22	Roche Announces Collaboration with Eli Lilly and Company to Enhance Early Diagnosis of ..	CI
03/22	Flare Therapeutics Inc. announced that it has received $123 million in funding from a g..	CI
03/21	Jacobio Pharma Announces Clinical Collaboration to Evaluate CD73 Monoclonal Antibody JA..	CI
03/21	Novartis' Sandoz Receives US FDA Approval for Biosimilar Hyrimoz Injection	MT
03/20	AbbVie Inc Files a Definitive Proxy Statement with Securities and Exchange Commission	CI
03/20	AbbVie Inc Files a Definitive Proxy Statement with Securities and Exchange Commission	CI
03/20	AbbVie Inc Files a Definitive Proxy Statement with Securities and Exchange Commission	CI
03/20	AbbVie Inc Solicits Proxies from the Shareholders	CI
03/20	Global markets live: UBS, Berkshire Hathaway, First Republic Bank, G..
03/20	Novo Nordisk Replenishes Supplies of Diabetes Drug Ozempic After Shortages	MT
03/17	Eli Lilly and Company Receives a Shareholder Proposal from The Service Employees Intern..	CI
03/17	Eli Lilly and Company Receives a Shareholder Proposal from John Chevedden	CI
03/17	Eli Lilly and Company Receives a Shareholder Proposal from Trinity Health	CI
03/17	Eli Lilly and Company Receives a Shareholder Proposal from National Center for Public P..	CI
03/17	Eli Lilly and Company Receives a Shareholder Proposal from Curtis Overway	CI
03/17	Eli Lilly and Company Receives a Shareholder Proposal from CommonSpirit Health	CI
03/17	Eli Lilly and Company Receives a Shareholder Proposal from Change Finance, P.B.C.	CI
03/17	Financial Stocks Burden European Equities Again Friday Trading	MT
03/16	France's Sanofi Joins Rivals in Slashing US Insulin Prices	MT
03/16	Merck Says Open-Label Arm of Phase 2 Trial of MK-7684A to Treat Lung Cancer Didn't Reac..	MT
03/16	Sanofi to cut US price of its most-prescribed insulin by 78%	RE
03/16	Sanofi to cut price of its most-prescribed insulin by 78% in US	RE
03/16	Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-76..	CI
03/16	Novo Nordisk Suspended From British Industry Group Over Marketing of Weight-Loss Drug	DJ
03/16	Novo Nordisk Suspended From UK Pharma Association for 2 Years Over Weight Loss Drug Pro..	MT
03/16	Novo Nordisk Suspended From UK Pharma Association for 2 Years Over Weight Loss Drug Pro..	MT
03/16	Pharmanovia to Buy License to Ghryvelin from Aeterna Zentaris' Existing Licensee, Consi..	MT
03/16	Novo Nordisk Suspended from British Pharmaceutical Industry Association for Two Years	MT
03/16	Novo Nordisk suspended from UK trade association for "serious breaches"	RE
03/15	Insider Sell: Abbvie	MT
03/15	Johnson & Johnson Unit Janssen Says Pre-Clinical Results Showed Dengue Candidate Drug D..	MT
03/15	Transcript : Merck & Co., Inc. Presents at Barclays Global Healthcare Confere..	CI
03/15	Transcript : AbbVie Inc. Presents at Barclays Global Healthcare Conference, M..	CI
03/15	AbbVie's, Gilead's Prescription Therapies Among 27 Drugs Subject to Medicare Inflation ..	MT
03/15	Halozyme Therapeutics Reaffirms 2023 Revenue Guidance After Partner Janssen's Patent Re..	MT
03/15	Johnson & Johnson Receives Shareholder Proposal from Oxfam America Inc	CI
03/15	Johnson & Johnson Receives Shareholder Proposal from Hal Scott/The Doris Behr 2012 Irre..	CI
03/15	Johnson & Johnson Receives Shareholder Proposal from Vermont Pension Investment Commiss..	CI
03/15	Johnson & Johnson Receives Shareholder Proposal from Mercy Investment Services Inc	CI
03/15	Mediar Therapeutics, Inc. announced that it has received $85.034866 million in funding ..	CI
03/14	Eli Lilly and Company Announces to Present Data from Oncology Portfolio At the American..	CI
03/14	Novo Nordisk to Reduce US Insulin Prices Starting Next Year	MT
03/14	Transcript : Johnson & Johnson Presents at Barclays Global Healthcare Confere..	CI
03/14	Novo Nordisk to Cut US Prices for Insulin Drugs by Up to 75%	MT
03/14	Novo Nordisk to Lower Insulin Product Prices in 2024	MT
03/14	Novo Nordisk to cut price of insulin by up to 75% - WSJ	RE
03/14	NOVO NORDISK : Gets a Buy rating from Deutsche Bank	MD
03/14	Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclona..	CI
03/14	Switch Therapeutics Inc. announced that it has received $52 million in funding from a g..	CI
03/13	Insider Sell: Eli Lilly	MT
03/13	Cinven interest in Synlab after high share price losses	DP
03/13	Wells Fargo Upgrades Eli Lilly to Overweight From Equalweight, Adjusts Price Target to ..	MT
03/13	Wells Fargo Downgrades Merck & Company to Equal Weight From Overweight, Adjusts Price T..	MT
03/13	Hainan Poly Pharm’s Dobutamine Drug Passes Consistency Evaluation	MT
03/13	Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation	RE
03/13	Galderma posts 2022 revenue growth ahead of planned IPO	RE
03/12	Merck & Co.'s Keytruda Extends Patients' Survival in Rare Lung Cancer Study	MT
03/11	Economists warn of costs if US Medicare covers new obesity drugs	RE
03/10	AbbVie Unit Allergan's Stomach Ulcer Medication Pylera Starts Shipping in US, Endo Inte..	MT
03/10	Merck Says Phase 2/3 Trial of Combination Cancer Therapy Met Primary Endpoint of Overal..	MT
03/10	Berenberg Bank Adjusts Merck & Company Price Target to $130 From $125, Maintains Buy Ra..	MT
03/10	Merck & Co., Inc. Announces the Phase 2/3 CCTG IND.227/KEYNOTE-483 Trial Evaluating KEY..	CI
03/09	US Lawmakers Introduce Bill Capping Insulin Price at $20 Per Vial	MT

Analysis

The long-running crisis at Japan's Toshiba

CHUGAI PHARMACEUTICAL CO., LTD